Yahoo! Finance: UCB.BR NewsCopyright (c) 2009 Yahoo! Inc. All rights reserved.http://finance.yahoo.com/q/h?s=ucb.brLatest Financial News for UCBen-usThu, 10 Dec 2009 15:08:51 Etc/GMThttp://us.news2.yimg.com/us.yimg.com/p/fi/pr/40197.gifYahoo! Financehttp://finance.yahoo.com14417UPDATE - Glaxo plans to outgrow rivals in emerging markets (at Reuters)http://us.rd.yahoo.com/finance/external/reuters/rss/SIG=118cks9u6/*http%3A//www.reuters.com/legacyArticle?duid=mtfh29704_2009-12-10_15-08-51_gee5b91q6_newsml&rpc=44&type=marketsNewsyahoo_finance/405290786Thu, 10 Dec 2009 15:08:51 Etc/GMTEURO BONDS-AKZO, Delta Lloyd, InterContinental, KA Finanz (at Reuters)http://us.rd.yahoo.com/finance/external/reuters/rss/SIG=118cks9u6/*http%3A//www.reuters.com/legacyArticle?duid=mtfh37042_2009-12-03_11-59-11_gee5b20ic_newsml&rpc=44&type=marketsNewsyahoo_finance/171210305Thu, 3 Dec 2009 11:59:11 Etc/GMTIsmail Kola joins UCB as Executive Vice President, UCB & President of UCB New Medicines(TM) (Marketwire)http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/091110/0557290.html?.v=1yahoo_finance/1911764184Tue, 10 Nov 2009 07:31:00 Etc/GMTInterim Report - Promising early results for UCB's new products (Marketwire)http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/091022/0550383.html?.v=1yahoo_finance/253777838Thu, 22 Oct 2009 05:14:00 Etc/GMTCimzia®, the only PEGylated anti-TNF, approved in Europe and available in a syringe designed in partnership with OXO Good Grips® (Marketwire)http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/091005/0544080.html?.v=1yahoo_finance/84551786Mon, 5 Oct 2009 13:46:00 Etc/GMTUCB and AstraZeneca form alliance for the commercialization of Cimzia(R) in Brazil (Marketwire)http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/090928/0541328.html?.v=1yahoo_finance/1667618121Mon, 28 Sep 2009 05:05:00 Etc/GMTUCB and Immunomedics announce positive results for epratuzumab phase IIb study in systemic lupus erythematosus (SLE) (Marketwire)http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/090827/0531619.html?.v=1yahoo_finance/1572983889Thu, 27 Aug 2009 05:06:00 Etc/GMTUCB and Novartis to expand cooperation in Germany (Marketwire)http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/090824/0530367.html?.v=1yahoo_finance/174406263Mon, 24 Aug 2009 05:13:00 Etc/GMTUCB and its design partners, OXO(R) and Smart Design, win 2009 "Red Dot: Communication Design" (Marketwire)http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/090812/0527215.html?.v=1yahoo_finance/3801887350Wed, 12 Aug 2009 06:02:00 Etc/GMTUCB progress: new product launches and financials on track (Marketwire)http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/090731/0523806.html?.v=1yahoo_finance/1686734762Fri, 31 Jul 2009 05:07:00 Etc/GMTUCB receives CHMP positive opinion on Keppra(R) for infants and young children with partial-onset epilepsy (Marketwire)http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/090724/0521967.html?.v=1yahoo_finance/296440640Fri, 24 Jul 2009 16:14:00 Etc/GMTUCB and Biogen Idec discontinue Phase II clinical trial of CDP323 (Marketwire)http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/090630/0515455.html?.v=2yahoo_finance/594365204Tue, 30 Jun 2009 20:39:00 Etc/GMTUCB brings Neupro(R) back to all patients in Europe (Marketwire)http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/090629/0514701.html?.v=2yahoo_finance/3714475657Mon, 29 Jun 2009 06:07:00 Etc/GMTCimzia(R), the only PEGylated anti-TNF, recommended for approval in the EU for rheumatoid arthritis (Marketwire)http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/090626/0514293.html?.v=2yahoo_finance/2445841302Fri, 26 Jun 2009 09:55:00 Etc/GMTUCB receives CHMP positive opinion on bringing Neupro(R) back to all patients in Europe (Marketwire)http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/090529/0505781.html?.v=1yahoo_finance/1402220815Fri, 29 May 2009 12:15:00 Etc/GMTUCB launches Vimpat(R) in the U.S. for add-on treatment of epilepsy in adults (Marketwire)http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/090526/0504540.html?.v=1yahoo_finance/2964613312Tue, 26 May 2009 16:28:00 Etc/GMTChange in UCB's Executive Committee (Marketwire)http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/090520/0503308.html?.v=1yahoo_finance/3551737565Wed, 20 May 2009 16:18:00 Etc/GMTPartnership unites UCB with consumer product innovator OXO(R) (Marketwire)http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/090514/0501185.html?.v=3yahoo_finance/577818375Thu, 14 May 2009 05:15:00 Etc/GMTUCB's CIMZIA(R) (certolizumab pegol) Approved by the U.S. FDA for Adult Patients Suffering From Moderate to Severe Rheumatoid Arthritis (Marketwire)http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/090513/0501147.html?.v=3yahoo_finance/3309504302Thu, 14 May 2009 00:20:00 Etc/GMTUCB seeking to acquire remaining Schwarz Pharma shares (Marketwire)http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/090508/0499403.html?.v=2yahoo_finance/964951848Fri, 8 May 2009 15:28:00 Etc/GMT